My HPRA: Register

CANDESARTAN/HYDROCHLOROTHIAZIDE TEVA

16/12.5 Milligram Tablets

Teva Pharma B.V.PA0749/192/001

Main Information

Trade NameCANDESARTAN/HYDROCHLOROTHIAZIDE TEVA
Active SubstancesCANDESARTAN CILEXETIL
HYDROCHLOROTHIAZIDE
Strength16/12.5 Milligram
Dosage FormTablets
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/192/001

Group Information

ATC CodeC09DA06 Angiotensin II antagonists and diuretics

Status

Authorised/WithdrawnAuthorised
Licence Issued22/03/2013
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may be renewed (B)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListCandesartan/Hydrochlorothiazide 16/12.5mg Tablets
Interchangeable List CodeIC0029-036-002
Interchangeable List DocumentPDF of Interchangeable List
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.